Chronic Pain Provider: James L. Claiborn, Ph.D., ABPP, ACT

Photo of James M. Claiborn, Ph.D., ABPP, ACT
Click the image to be taken to the PES website.

Dr. Claiborn will provide Cognitive Behavioral Therapy (CBT) and psychological assessment. Assessments will be conducted by a psychologist and potentially reviewed by a senior psychologist. Specific elements of assessments will be determined on a case by case basis but will include a clinical interview, administration, and interpretation of a selected battery of tests. The resulting report will be of assistance to referring providers, individual and group therapists and others working with patients seen in the consortium.

The battery will be selected primarily from the following list of assessment instruments.

  •  Screener and Opioid Assessments for Patients with Pain (revised) [ SOAPP-R]. This is a measure designed to predict aberrant medication-related behaviors in chronic pain patients being considered for long-term opioid therapy. This will be of value to prescribers.
  •  Current Opioid Misuse Measure [COMM]. This is a self-report measure developed to identify medication misuse among people with chronic pain and detect current aberrant use of opiates. This will be of value to prescribers and therapists.
  • Opioid Risk Tool [ORT]. This is a brief self-report scale to assess the risk of opiate misuse before prescribing. This will be of value to prescribers.
  • Battery for Health Improvement [BHI]. This is a 150 item computer-scored inventory designed to examine coping styles and personality features of people with physical illnesses. There is normative data for patients with chronic pain and it is useful in predicting response to treatment and will be of value to all providers.
  • Millon Behavioral Medicine Diagnostic [MBMD]. This inventory identifies psychiatric illness and recommends specific interventions. It has norms for and a specific report for pain patients. This will be of value to all providers.
  • Minnesota Multiphasic Personality lnventory-2 RF [MMPl-2 RF]. The MMPI has been used extensively in evaluating pain patients. It helps identify psychopathology and is useful in predicting response to treatment, self-reported disability, motivation for change, substance abuse and secondary gain. There is a specific report available for chronic pain patients. This information will be of value to all providers.
  • McGill Pain questionnaire [McGill] This questionnaire consists of a list of adjectives used to describe the patients’ pain experience. It is typically combined with a diagram where the patient indicates the distribution and type of pain experienced. It is a classic part of pain assessment and provides information about the psychological and physical aspects of the individual’s pain experience. This information will be of value to all providers.